Evidence map›Paper›PMID 40312500›Full record

ArticleScientific reports2025

The differential impact of HNRNPA1 isoforms on gene expression and their relevance to dsRNA-mediated innate immune response.

Jade-Emmanuelle Deshaies, Valérie Triassi, Andréanne Lacombe, Myriam Gagné, Karen Ling, Asmita Ghosh, Marjorie Labrecque, Frank Rigo, Paymaan Jafar-Nejad, Martine Tétreault and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jade-Emmanuelle DeshaiesCentre hospitalier de l'Université de Montréal (CHUM) Research Center, Montréal, QC, Canada.
Valérie TriassiCentre hospitalier de l'Université de Montréal (CHUM) Research Center, Montréal, QC, Canada.
Andréanne LacombeCentre hospitalier de l'Université de Montréal (CHUM) Research Center, Montréal, QC, Canada.
Myriam GagnéCentre hospitalier de l'Université de Montréal (CHUM) Research Center, Montréal, QC, Canada.
Karen LingDepartment of Core Antisense Research, Ionis Pharmaceuticals, Inc, Carlsbad, CA, USA.
Asmita GhoshCentre hospitalier de l'Université de Montréal (CHUM) Research Center, Montréal, QC, Canada.
Marjorie LabrecqueCentre hospitalier de l'Université de Montréal (CHUM) Research Center, Montréal, QC, Canada.
Frank RigoDepartment of Core Antisense Research, Ionis Pharmaceuticals, Inc, Carlsbad, CA, USA.
Paymaan Jafar-NejadDepartment of Core Antisense Research, Ionis Pharmaceuticals, Inc, Carlsbad, CA, USA.
Martine TétreaultCentre hospitalier de l'Université de Montréal (CHUM) Research Center, Montréal, QC, Canada.
Christine Vande VeldeCentre hospitalier de l'Université de Montréal (CHUM) Research Center, Montréal, QC, Canada. c.vande.velde@umontreal.ca.

Funding

Natural Sciences and Engineering Research Council of Canada RGPIN-2022-04268
6 · The paper itself

Abstract

Heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1) is a highly abundant RNA binding protein alternatively spliced in two main isoforms named, hnRNP A1 and hnRNP A1B. While being ubiquitously expressed, both isoforms have different cellular localizations and are differentially expressed in tissues during development and aging. To improve our understanding of the cellular function of each isoform, we performed RNA sequencing in cells exclusively expressing hnRNP A1 or hnRNP A1B. As expected, some genes were commonly regulated, however > 300 genes were differentially regulated by the two isoforms. Functional annotation indicated an enrichment for genes implicated in cellular defense, especially for innate immunity and dsRNA response. Here, we demonstrate that in basal conditions, hnRNP A1, but not hnRNP A1B, represses interferon stimulated genes including the family of dsRNA sensors oligoadenylate synthases (OASs). Thus, the dsRNA-mediated interferon antiviral response can be potentiated by the loss of hnRNP A1-mediated repression.

Indexed as

Gene Expression RegulationHeterogeneous Nuclear Ribonucleoprotein A1Immunity, InnateRNA, Double-Stranded2',5'-Oligoadenylate SynthetaseAlternative SplicingHEK293 CellsHumansProtein Isoforms2',5'-Oligoadenylate SynthetaseHeterogeneous Nuclear Ribonucleoprotein A1hnRNPA1 protein, humanProtein IsoformsRNA, Double-StrandedDifferential gene expressionDouble-stranded RNAHNRNPA1Innate immunityIsoformsRNA sequencing (RNA-seq)

Identifiers

PMID40312500
PMCPMC12046027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.